Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/4/12 → 06/30/16 |
Funding
- Abbott Molecular Incorporated: $50,000.00
Evaluation and Treatment of Hepatitis C Virus (HCV) Infection by an onsite Health Care Provider with Specialist Support via Telemedicine in Patients on Opiate Agonist Therapy: A Non-Comparative, Feasibility Study
- Talal, Andrew (PI)
Project: Research